Literature DB >> 3890726

Determination of vancomycin in human serum by high-pressure liquid chromatography.

F Jehl, C Gallion, R C Thierry, H Monteil.   

Abstract

A rapid, accurate, reverse-phase high-pressure liquid chromatographic procedure for vancomycin quantitation in human serum, cerebrospinal fluid, and peritoneal fluid was developed. This procedure involves a simple chemical extraction of the antibiotic and is suitable for each of these body fluids. The column and mobile phase used provided a good resolution of the vancomycin peak with a retention time of 6.1 min. The precision of the assay was within the requirement for a daily routine clinical application. Coefficients of variation for within-day reproducibility were 5.80 and 6.28%, respectively, for samples at 50 and 25 micrograms/ml, and for between-day reproducibility they were 11.4 and 11.1%, respectively. No interference was found with respect to beta-lactam and aminoglycoside antibiotics and many other currently used drugs, indicating a good specificity for the procedure. The detection limit of 100 ng/ml has proven to be sufficient for monitoring drug levels in serum obtained after usual dosages. Drug levels in 112 clinical serum specimens assayed by high-pressure liquid chromatography were regressed against the levels obtained for the same samples by radioimmunoassay and fluorescent polarization immunoassay. Correlation coefficients were 0.945 and 0.967, respectively, and were highly significant (alpha less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890726      PMCID: PMC180084          DOI: 10.1128/AAC.27.4.503

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.

Authors:  B H Ackerman; H G Berg; R G Strate; J C Rotschafer
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

2.  Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.

Authors:  K B Crossley; J C Rotschafer; M M Chern; K E Mead; D E Zaske
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

3.  Comparison of five methods for the assay of serum gentamicin.

Authors:  R M Ratcliff; C Mirelli; E Moran; D O'Leary; R White
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

4.  Vancomycin therapy of experimental pneumococcal meningitis caused by penicillin-sensitive and resistant strains.

Authors:  T R Beam
Journal:  J Antimicrob Chemother       Date:  1981-01       Impact factor: 5.790

5.  Sensitive radioimmunoassay for vancomycin.

Authors:  K L Fong; D H Ho; L Bogerd; T Pan; N S Brown; L Gentry; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 6.  Vancomycin revisited.

Authors:  F V Cook; W E Farrar
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

7.  Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

Authors:  M S Engineer; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

8.  Single-dose kinetics of intravenous vancomycin.

Authors:  D J Krogstad; R C Moellering; D J Greenblatt
Journal:  J Clin Pharmacol       Date:  1980-04       Impact factor: 3.126

9.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

10.  High performance liquid chromatographic assay of vancomycin in serum.

Authors:  J R Uhl; J P Anhalt
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681

View more
  5 in total

1.  Localized mandibular infection affects remote in vivo bioreactor bone generation.

Authors:  Emma Watson; Brandon T Smith; Mollie M Smoak; Alexander M Tatara; Sarita R Shah; Hannah A Pearce; Katie J Hogan; Jonathan Shum; James C Melville; Issa A Hanna; Nagi Demian; Joseph C Wenke; George N Bennett; Jeroen J J P van den Beucken; John A Jansen; Mark E Wong; Antonios G Mikos
Journal:  Biomaterials       Date:  2020-06-23       Impact factor: 12.479

2.  Instability of vancomycin in Infusaid drug pump model 100.

Authors:  R N Greenberg; A M Saeed; D J Kennedy; R McMillian
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

4.  Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.

Authors:  G D Morse; D F Farolino; M A Apicella; J J Walshe
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Serum protein-binding characteristics of vancomycin.

Authors:  H Sun; E G Maderazo; A R Krusell
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.